HOGUE GERALD L. 4
4 · POINT Biopharma Global Inc. · Filed Jun 5, 2023
Insider Transaction Report
Form 4
HOGUE GERALD L.
Director
Transactions
- Award
Stock Option (Right to Buy)
2023-06-01+44,749→ 44,749 totalExercise: $9.12Exp: 2029-06-01→ Common Stock (44,749 underlying)
Footnotes (1)
- [F1]The option will vest 100% on the first anniversary of the grant date.